We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.16%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$44.5M
(+3.4%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
687
New
99
Increased
230
Reduced
280
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.2M |
| 2 |
Gilead Sciences
GILD
|
+$11.6M |
| 3 |
ConocoPhillips
COP
|
+$5.98M |
| 4 |
Morgan Stanley
MS
|
+$5.54M |
| 5 |
Capri Holdings
CPRI
|
+$3.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.9M |
| 2 |
American International
AIG
|
+$11.1M |
| 3 |
Texas Instruments
TXN
|
+$9.03M |
| 4 |
Prudential Financial
PRU
|
+$7.31M |
| 5 |
General Motors
GM
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.46% |
| 2 | Industrials | 14.03% |
| 3 | Technology | 11.99% |
| 4 | Healthcare | 11.73% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
251
Diversified Healthcare Trust
DHC
$2.15B
| $1.3M | 0.09% |
57,154
+45,493
| +390% | +$1.01M |
|
252
KLA
KLAC
$252B
| $1.29M | 0.09% |
184,560
-19,760
| -10% | -$142K |
|
253
Campbell Soup
CPB
$6.78B
| $1.27M | 0.09% |
+23,240
| New | +$1.41M |
|
|
GIG
254
DELISTED
GigPeak, Inc.
GIG
| $1.26M | 0.09% |
+535,730
| New | +$1.11M |
|
255
Viatris
VTRS
$20.6B
| $1.26M | 0.09% |
33,014
+11,395
| +53% | +$507K |
|
256
Cincinnati Financial
CINF
$27.6B
| $1.26M | 0.09% |
16,648
-621
| -4% | -$47K |
|
257
AvalonBay Communities
AVB
$27.1B
| $1.25M | 0.09% |
7,024
-580
| -8% | -$104K |
|
258
Pilgrim's Pride
PPC
$6.4B
| $1.25M | 0.09% |
59,118
-42
| -0.1% | -$974 |
|
259
US Physical Therapy
USPH
$1.16B
| $1.25M | 0.09% |
19,880
+6,667
| +50% | +$411K |
|
260
L3Harris
LHX
$53.6B
| $1.23M | 0.09% |
13,443
-1,425
| -10% | -$127K |
|
261
Mattel
MAT
$4.26B
| $1.23M | 0.09% |
40,608
-1,906
| -4% | -$62.3K |
|
262
Republic Services
RSG
$63.6B
| $1.23M | 0.09% |
24,342
-1,532
| -6% | -$78.5K |
|
263
Everest Group
EG
$14.3B
| $1.21M | 0.09% |
6,356
-3,292
| -34% | -$619K |
|
264
Annaly Capital Management
NLY
$17B
| $1.21M | 0.09% |
28,680
+17,174
| +149% | +$744K |
|
|
BSFT
265
DELISTED
BroadSoft, Inc.
BSFT
| $1.21M | 0.09% |
25,891
-863
| -3% | -$38.5K |
|
266
Equity Residential
EQR
$25.4B
| $1.2M | 0.09% |
18,591
-319
| -2% | -$21.3K |
|
|
PGNX
267
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.19M | 0.09% |
188,299
-4,376
| -2% | -$26.5K |
|
268
Crown Castle
CCI
$31.3B
| $1.19M | 0.09% |
12,645
-2,949
| -19% | -$284K |
|
269
Insteel Industries
IIIN
$641M
| $1.19M | 0.09% |
32,706
-220
| -0.7% | -$7.42K |
|
|
RRD
270
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.18M | 0.09% |
+25,017
| New | +$1.29M |
|
271
UnitedHealth
UNH
$372B
| $1.18M | 0.09% |
8,422
+1,490
| +21% | +$209K |
|
272
Ventas
VTR
$47.4B
| $1.17M | 0.09% |
16,603
+647
| +4% | +$47K |
|
273
Argan
AGX
$8.56B
| $1.17M | 0.09% |
19,778
-667
| -3% | -$32.7K |
|
274
Preferred Bank
PFBC
$1.27B
| $1.17M | 0.09% |
32,711
-1,344
| -4% | -$45.2K |
|
275
Williams-Sonoma
WSM
$29.6B
| $1.17M | 0.09% |
45,706
+6,694
| +17% | +$175K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cadence Capital Management held 687 positions worth $1.37B, up 3.4% from $1.33B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Cadence Capital Management's Q3 2016 filing shows 99 new, 230 increased, 280 reduced and 72 closed positions. Its largest new stake was Bristol-Myers Squibb: 190,283 shares worth $10.3M. The largest sale was Apple, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
- Cadence Capital Management's largest Q3 2016 buy was Bristol-Myers Squibb: 190,283 shares worth $10.3M.
- Cadence Capital Management added most to Gilead Sciences in Q3 2016, an estimated $11.6M increase.
- Cadence Capital Management's biggest Q3 2016 reduction was Apple, cutting an estimated $11.9M.
- Cadence Capital Management fully exited American International in Q3 2016, selling an estimated $11.1M.
- Cadence Capital Management's ten largest holdings make up 10% of its $1.37B portfolio in Q3 2016.
- Cadence Capital Management opened 99 new positions and closed 72 in Q3 2016.
- Cadence Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.37B.
Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.